Humanoid Global Holdings Corp. has completed a non-brokered private placement of special warrants, issuing 2,500,000 at $0.80 each for $2,000,000 in gross proceeds. Each warrant will convert into one common share and one transferable common share purchase warrant. The company may file a prospectus supplement to convert the warrants. Additionally, the company paid finder’s fees totaling $133,000 and issued 166,250 finder’s warrants. All securities issued are subject to a statutory hold period ending on February 25, 2026. The net proceeds will be used for general working capital purposes. The company has realized gross proceeds of $74,425 from the sale of investments and $229,710 from exercised warrants. The former CEO has sent a demand letter, which is under review, and the company believes the allegations are without merit. Management remains confident in the company’s strategic direction.
Humanoid Global Holdings Corp. is a publicly traded investment issuer focusing on companies in humanoid robotics and embodied AI. Led by a team with a proven track record, the company provides capital and strategic consultation, facilitating introductions to customers, suppliers, and partners. For more information, contact Shahab Samimi, CEO at [email protected] or [email protected], or call (604) 602-0001. The CSE does not accept responsibility for the adequacy or accuracy of this release. The news release contains forward-looking information regarding the company’s business plans, growth strategy, and expectations. While the company believes these statements are reasonable, they involve risks and uncertainties. Investors are cautioned not to rely solely on forward-looking statements and to consider potential risks.
Read more at GlobeNewswire: Humanoid Global Announces Closing of Special Warrant
